|
- Xenios AG is specialized in extracorporeal heart and lung support
Xenios AG, a Fresenius Medical Care company, receives approval from National Medical Products Administration (NMPA) in China for the Xenios console and patient kits for ECMO therapy
- ECLS with XENIOS 2. 0 - Xenios AG
Xenios 2 0 is the all-new ECMO system providing cutting-edge safety features to enable treatments for neonate to adult patients The redesigned user interface with intelligent troubleshooting and enhanced connectivity can reduce the workload for the ECMO team
- Fresenius Medical Care is taking the next step in extracorporeal life . . .
Fresenius Medical Care’s heart lung business unit, Xenios AG, introduces the all-new Xenios 2 0 This system enables healthcare professionals to take the next step in extracorporeal life support (ECLS)
- About us - Xenios AG
Xenios AG, a Fresenius Medical Care company, delivers quality products while adhering to the highest ethical standards and practices in the industry Our Code of Conduct provides useful guidance for the holding and single companies or therapy brands
- Xenios 2. 0 – Taking the next step in ECLS
End of 2016, Xenios became a part of Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure www freseniusmedicalcare com
- Patient kits: From CO2 removal to full oxygenation - Xenios AG
Xenios patient kits provide treatments for heart and lung failures Different oxygenator sizes enable treatments from neonates to adults
- ECLS with Xenios console
The Xenios console is the core of our extracorporeal life support (ECLS) offering The console, equipped with the right patient kit and cannulas, determines the type of extracorporeal treatment
- Heart Lung Media Center - Xenios AG
Find all current brochures, technical data sheets, videos and publications in our Heart Lung media center
|
|
|